Delivery Order SPE2DB25D7067-SPE2DB25FSVPX
- Not listed
- The Defense Logistics Agency awarded a $4,949.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5mL vials. Issued on August 11, 2025, with an ultimate completion date of August 12, 2025, this competitively awarded contract (no set-aside used) will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,164.10 on August 12, 2025, for the supply of Pediarix HIB vaccine in 0.5mL vials. This contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pediarix HIB vaccine in 0.5 milliliter vials, with a ceiling value of $1,326.85 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,462.95 to AmerisourceBergen Drug Corp for the supply of Pediarix/PedvaxHIB vaccine vials (0.5 mL) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is listed as the...
- The U.S. Defense Logistics Agency awarded a $3,663.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix vaccine vials (0.5mL) on August 7, 2025, with completion expected by August 8, 2025. This is a competitive award with no set-aside designation, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $3,261.55 for Pediarix 0.5 ML syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $8,506 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be performed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and a key...
- The Defense Logistics Agency awarded a delivery order valued at $2,920.27 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery of the pediatric vaccine product to support federal medical supply requirements. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,166.15 firm fixed price delivery order for Pediarix 0.5 mL syringes, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVPXDelivery Order
The Defense Logistics Agency awarded a $1,327.13 delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix Haemophilus influenzae type b (Hib) vaccine in 0.5mL vials. This is a firm fixed price, non-competitive set-aside delivery order with a completion date of August 20, 2025, issued just one day prior. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and healthcare systems and is the performing location for this contract. This delivery order represents a draw against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses vaccines, specialty medications, and other medical commodities across multiple therapeutic domains, positioning AmerisourceBergen as a key supplier for Defense Health Agency requirements and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/19/25 |